Story · Medicine & Biotech

Nilay Sethi։ How Should We Interpret Mutational Signatures in Cancer Survivors?

1 outlet · first reported by OncoDaily on

Nilay Sethi, Associate Professor at Harvard Medical School, shared Journal of Clinical Investigation’s post on LinkedIn, adding: “Please share thoughts and feedback on our commentary in The Journal of Clinical (OncoDaily)

Coverage, in order

  1. OncoDaily obscure opinion
    Nilay Sethi։ How Should We Interpret Mutational Signatures in Cancer Survivors?

    Nilay Sethi, Associate Professor at Harvard Medical School, shared Journal of Clinical Investigation’s post on LinkedIn, adding: “Please share thoughts and feedback on our commentary in The Journal of Clinical

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.